Risk‐adapted stereotactic body radiation therapy for central and ultra‐central early‐stage inoperable non‐small cell lung cancer

To determine the therapeutic efficacy and safety of risk‐adapted stereotactic body radiation therapy (SBRT) schedules for patients with early‐stage central and ultra‐central inoperable non‐small cell lung cancer. From 2006 to 2015, 80 inoperable T1‐2N0M0 NSCLC patients were treated with two median d...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Mao‐Bin, Wang, Huan‐Huan, Zaorsky, Nicholas G., Sun, Bing‐Shen, Zhu, Lei, Song, Yong‐Chun, Li, Feng‐Tong, Dong, Yang, Wang, Jing‐Sheng, Chen, Hua‐Ming, Yu, Xu‐Yao, Yuan, Zhi‐Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825012/
https://www.ncbi.nlm.nih.gov/pubmed/31464032
http://dx.doi.org/10.1111/cas.14185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825012/
https://www.ncbi.nlm.nih.gov/pubmed/31464032
http://dx.doi.org/10.1111/cas.14185

Ejemplares similares